Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery

British Journal of Pharmacology

Volumn 118, Issue 5, 1996, Pages 1147-1152

  Zygmunt, Peter M ^a   Edwards, Gillian ^b   Weston, Arthur H ^b   Davis, S Christopher ^c   Högestätt, Edward D ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arachidonic acid; Cytochrome P450; Epoxyeicosatrienoic acid; Hyperpolarization; Membrane potential; Nitric oxide; Potassium channels; Vascular endothelium

Indexed keywords

ACETYLCHOLINE; CLOTRIMAZOLE; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENZYME INHIBITOR; INDOMETACIN; LEMAKALIM; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM ION; PROADIFEN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HEPATIC ARTERY; HYPERPOLARIZATION; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0030018728     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15517.x     Document Type: Article

References (35)

1. ABRAHAM, N.G., PINTO, A., MULLANE, K.M., LEVERE, R.D. & SPOKAS, K. (1985). Presence of cytochrome P-450-dependent monooxygenase in intimal cells of the hog aorta. Hypertension, 7, 899-904.
2. + channels by cytochrome P-450 inhibitors. J. Biol. Chem. 267, 11789-11793.
3. BAUERSACHS, J., HECKER, M. & BUSSE, R. (1994). Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br. J. Pharmacol., 113, 1548-1553.
4. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest., 92, 520- 526.
5. CARROLL, M.A., GARCIA, M.P., FALCK, J.R. & MCGIFF, J.C. (1990). 5,6-Epoxyeicosatrienoic acid, a novel arachidonate metabolite. Circ. Res., 67, 1082-1088.
6. CORRIU, C., FELETOU, M., CANET, E. & VANHOUTTE, P.M. (1996). Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery. Br. J. Pharmacol. 117, 607-610.
7. EDWARDS, G. & WESTON, A.H. (1993). The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol., 33, 597-637.
8. ELLIS, E.F., AMRUTHESH, S.C., POLICE, R.J. & VANCEY, L.M. (1990). Brain synthesis and cerebrovascular action of cytochrome P-450 monooxygenase metabolites of arachidonic acid. Adv. Prostaglandins Thromboxane Leukotriene Res., 21, 201-204.
9. FULTON, D., MAHBOUBI, K., MCGIFF, J.C. & QUILLEY, J. (1995). Cytochrome P450-dependent effects of bradykinin in the rat heart. Br. J. Pharmacol., 114, 99-102.
10. FULTON, D., MCGIFF, J.C. & QUILLEY, J. (1992). Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br. J. Pharmacol., 107, 722-725.
11. FULTON, D., MCGIFF, J.C. & QUILLEY, J. (1994). Role of K channels in the vasodilator response to bradykinin in the rat heart. Br. J. Pharmacol., 113, 954-958.
12. GARLAND, C.J., PLANE, F., KEMP, B.K. & COCKS, T.M. (1995). Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci., 16, 23-30.
13. GEBREMEDHIN, D., MA, Y.-H., FALCK, J.R., ROMAN, R.J., VANROLLINS, M. & HARDER, D.R. (1992). Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am. J. Physiol., 263, H519-H525.
14. HARDER, D.R., CAMPBELL, W.B. & ROMAN, R.J. (1995). Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res., 32, 79-92.
15. HECKER, M., BARA, A.T., BAUERSACHS, J. & BUSSE, R. (1994). Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol., 481, 407-414.
16. HÖGESTÄTT, E.D., ANDERSSON, K.-E. & EDVINSSON, L. (1983). Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol. Scand., 117, 49-61.
17. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur. J. Pharmacol., 230, 215-221.
18. KALSNER, S., NICKERSON, M. & BOYD, G.N. (1970). Selective blockade of potassium-induced contractions of aortic strips by β-diethylaminoethyl-diphenylpropylacetate (SKF 525A). J. Pharmacol. Exp. Ther., 174, 500-508.
19. KOMORI, K. & VANHOUTTE, P.M. (1990). Endothclium-derived hyperpolarizing factor. Blood Vessels, 27, 238-245.
20. LISCHKE, V., BUSSE, R. & HECKER, M. (1995). Selective inhibition by barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br. J. Pharmacol., 115, 969-974.
21. MURRAY, M. & REIDY, G.L. (1990). Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev., 42, 85-101.
22. PETHRSSON, J., ZYOMUNT, P.M., BRANDT, L. & HÖGHSTÄTT, E.D. (1995). Substance P-induced relaxation and hyperpolarization in human cerebral arteries. Br. J. Pharmacol., 115, 889-894.
23. PFISTER, S.L., FALCK, J.R. & CAMPBELL, W.B (1991). Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. Am. J. Physiol., 261, H843-H852.
24. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am. J. Physiol., 264, H327-H335.
25. SHAK, S., REICH, N.O., GOLDSTEIN, I.M. & ORTIZ DE MONTELLANO, P.R. (1985). Leukotriene B4 ω-hydroxylase in human polymorphonuclear leukocytes: suicidal inactivation by acetylenic fatty acids. J. Biol. Chem., 260, 13023-13028.
26. SUZUKI, H. & CHEN, G. (1990). Endothelium-derived hyperpolarizing factor (EDHF): an endogenous potassium-channel activator. News Physiol. Sci., 5, 212-215.
27. TAYLOR, W.J., WOLF, A. & YOUNG, J.M. (1980). The interaction of amine local anaesthetics with muscarinic receptors. Br. J. Pharmacol., 71, 327-335.
28. TRIGGLE, C.R., SWAMY, V.C. & TRIGGLE, D.J. (1979) Calcium antagonists and contractile responses in rat vas deferens and guinea pig ileal smooth muscle. Can. J. Physiol. Pharmacol., 57, 804-818.
29. 3 and chromaffin cells by imidazole antimycotics and other cytochrome P450 blockers. FASEB J., 6, 2742-2747.
30. ZOU, A.-P., IMIG, J.D., KALDUNSKI, M., ORTIZ DE MONTELLANO, P.R., SUI, Z. & ROMAN, R.J. (1994a). Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am. J. Physiol., 266, F275-F282.
31. ZOU, A.-P., MA, Y.-H., SUI, Z-.H., ORTIZ DE MONTELLANO, P.R., CLARK, J.E., MASTERS, B.S. & ROMAN, R.J. (1994b). Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function in rats. J. Pharmacol. Exp. Ther., 268, 474-481.
32. ZYGMUNT, P.M., GRUNDEMAR, L. & HÖGESTÄTT, E.D. (1994a). Endothelium-dependent relaxation resistant to Nω-nitro-L-arginine in the rat hepatic artery and aorta. Acta Physiol. Scand., 152, 107-114.
33. ZYGMUNT, P.M. & HÖGESTÄTT, E.D. (1996). Role of potassiumchannels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol., 117, 1600-1606.
34. ZYGMUNT, P.M., HÖGESTÄTT, E.D., EDWARDS, G., ORTIZ DE MONTELLANO, P.R. & WESTON, A.H. (1996). Effects of cytochrome P450 inhibitors on endothelium-dependent and levcromakalim-induced responses in rat blood vessels. Br. J. Pharmacol. Proc. Suppl., 117, 120p.
35. ZYGMUNT, P.M., WALDECK, K. & HÖGESTÄTT, E.D. (1994b). The endothelium mediates a nitric oxide-independent hyperpolarization and relaxation in the rat hepatic artery. Acta Physiol. Scand., 152, 375-384.